This first comprehensive overview on nanotechnological approaches to cancer therapy brings together therapeutic oncology and nanotechnology, showing the various strategic approaches to selectively eliminating cancerous cells without damaging the surrounding healthy tissue. The strategies covered include magnetic, optical, microwave and neutron absorption techniques, nanocapsules for active agents, nanoparticles as active agents, and active and passive targeting, while also dealing with fundamental aspects of how nanoparticles cross biological barriers.A valuable single source gathering the…mehr
This first comprehensive overview on nanotechnological approaches to cancer therapy brings together therapeutic oncology and nanotechnology, showing the various strategic approaches to selectively eliminating cancerous cells without damaging the surrounding healthy tissue. The strategies covered include magnetic, optical, microwave and neutron absorption techniques, nanocapsules for active agents, nanoparticles as active agents, and active and passive targeting, while also dealing with fundamental aspects of how nanoparticles cross biological barriers.A valuable single source gathering the many articles published in specialized journals often difficult to locate for members of the other disciplines involved.
Challa Kumar is currently the Group Leader of Nanofabrication at the Center for Advanced Microstructures and Devices (CAMD), Baton Rouge, USA. His research interests are in developing novel synthetic methods for functional nanomaterials and innovative therapeutic, diagnostic and sensory tools based on nanotechnology. He has eight years of industrial R&D experience working for Imperial Chemical Industries and United Breweries prior to joining CAMD. He is the founding Editor-in-Chief of the Journal of Biomedical Nanotechnology, an international peer reviewed journal published by American Scientific Publishers, and the series editor for the ten-volume book series Nanotechnologies for the Life Sciences (NtLS) published by Wiley-VCH. He worked at the Max Planck Institute for Biochemistry in Munich, Germany, as a post doctoral fellow and at the Max Planck Institute for Carbon Research in Mülheim, Germany, as an invited scientist. He obtained his Ph.D. degree in synthetic organic chemistry from Sri Sathya Sai Institute of Higher Learning, Prashanti Nilayam, India.
Inhaltsangabe
Chapter 1: Conventional chemotherapeutic drug nanoparticles for cancer treatment
Chapter 2: Nanoparticles for photodynamic therapy of cancer
Chapter 3: Nanoparticles for Neutron Capture Therapy of Cancer
Chapter 4: Nano vehicles and high molecular weight delivery agents for Boron Neutron capture therapy
Chapter 5: Local cancer therapy with magnetic drug targeting using magnetic nanoparticles
Chapter 6: Nanomaterials for controlled release of anticancer agents
Chapter 7: Critical analysis of cancer therapy using nanomaterials
Chapter 8: Nanoparticles for thermotherapy
Chapter 9: Ferromagnetic filled carbon nanotubes as novel and potential containers for anticancer treatment strategies
Chapter 10: Lyposomes, dendrimers and other nanoparticles for targeted delivery of anticancer agents - a comparative study
Chapter 11: Colloidal systems for the delivery of anticancer agents in breast cancers and multiple Myeloma
